RiverVest Venture Fund IV, L.P. [Rocket]

Date	Name	Type	Security	Shares	Price	Value	Ownership	Reported
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Common Stock	832.1k	$0.00	$0	See Footnotes	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Common Stock	359.3k	$0.00	$0	See Footnotes	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Purchase	Common Stock	250k	$16.00	$4M	See Footnotes	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Series B Preferred Stock	832.1k	$0.00	$0	See Footnotes	10/26/2021
10/26/2021	Xilio Therapeutics, Inc.	Conversion	Series B Preferred Stock	359.3k	$0.00	$0	See Footnotes	10/26/2021